Search research articles
Contact Us
Filters
Showing results (11-20 of 86) with videos related to
Page
of 9
Sort By:
Clinical Pharmacology and Therapeutics
|
October 1, 1995
The fate of naringin in humans: a key to grapefruit juice-drug interactions?
U Fuhr, A L Kummert
Pharmacogenetics
|
June 1, 1994
Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva
U Fuhr, K L Rost
Deutsche Medizinische Wochenschrift (1946)
|
February 12, 1998
[Theophylline]
A H Staib, U Fuhr
Clinical Pharmacology and Therapeutics
|
January 30, 2007
Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach
U Fuhr, A Jetter, J Kirchheiner
Annales De Radiologie
|
May 1, 1975
[Skeletal manifestations in Down's syndrome. Correlation between roentgenologic and cytogenetic findings]
E Willich, U Fuhr, W Kroll
European Journal of Clinical Pharmacology
|
February 3, 2007
Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping
D Frank, U Jaehde, U Fuhr
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
August 1, 1977
[Skeletal changes in Down's syndrome. A correlation between radiological and cytogenetic findings (author's transl)]
E Willich, U Fuhr, W Kroll
International Journal of Clinical Pharmacology and Therapeutics
|
February 1, 1997
Pharmacokinetic interactions of antineoplastic agents
R A Rao-Schymanski, U Fuhr
European Journal of Clinical Pharmacology
|
January 1, 1992
Verapamil and drug metabolism by the cytochrome P450 isoform CYP1A2
U Fuhr, B G Woodcock, M Siewert
British Journal of Clinical Pharmacology
|
April 1, 1993
Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man
U Fuhr, K Klittich, A H Staib
Page
of 9
Search research articles
Search
Showing results (11-20 of 86) with videos related to
Sort By:
Page
of 9
Clinical Pharmacology and Therapeutics
|
October 1, 1995
The fate of naringin in humans: a key to grapefruit juice-drug interactions?
U Fuhr, A L Kummert
Pharmacogenetics
|
June 1, 1994
Simple and reliable CYP1A2 phenotyping by the paraxanthine/caffeine ratio in plasma and in saliva
U Fuhr, K L Rost
Deutsche Medizinische Wochenschrift (1946)
|
February 12, 1998
[Theophylline]
A H Staib, U Fuhr
Clinical Pharmacology and Therapeutics
|
January 30, 2007
Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach
U Fuhr, A Jetter, J Kirchheiner
Annales De Radiologie
|
May 1, 1975
[Skeletal manifestations in Down's syndrome. Correlation between roentgenologic and cytogenetic findings]
E Willich, U Fuhr, W Kroll
European Journal of Clinical Pharmacology
|
February 3, 2007
Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping
D Frank, U Jaehde, U Fuhr
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
August 1, 1977
[Skeletal changes in Down's syndrome. A correlation between radiological and cytogenetic findings (author's transl)]
E Willich, U Fuhr, W Kroll
International Journal of Clinical Pharmacology and Therapeutics
|
February 1, 1997
Pharmacokinetic interactions of antineoplastic agents
R A Rao-Schymanski, U Fuhr
European Journal of Clinical Pharmacology
|
January 1, 1992
Verapamil and drug metabolism by the cytochrome P450 isoform CYP1A2
U Fuhr, B G Woodcock, M Siewert
British Journal of Clinical Pharmacology
|
April 1, 1993
Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man
U Fuhr, K Klittich, A H Staib
Page
of 9